Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.46
    +2.34 (+0.31%)
     
  • GBP/EUR

    1.1672
    +0.0016 (+0.13%)
     
  • GBP/USD

    1.2472
    -0.0039 (-0.31%)
     
  • Bitcoin GBP

    50,897.34
    -507.47 (-0.99%)
     
  • CMC Crypto 200

    1,322.59
    -73.95 (-5.30%)
     
  • S&P 500

    5,099.93
    +51.51 (+1.02%)
     
  • DOW

    38,244.25
    +158.45 (+0.42%)
     
  • CRUDE OIL

    83.86
    +0.29 (+0.35%)
     
  • GOLD FUTURES

    2,348.30
    +5.80 (+0.25%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Investing in Biotech is a Long Game: Schulman

Feb.26 -- Polaris Partners Managing Partner Amy Schulman says that the key to investing in biotech is to diversify by investing in a portfolio. She cautions that biotech investments can be risky, but says the successes are spectacular. She joins David Westin on "Bloomberg Wall Street Week."